Patient info Open main menu
  1. Patient info
  2. » Patient leaflets
  3. » REBOXETINE 4 MG TABLETS,EDRONAX 4 MG TABLETS - patient leaflet, side effects, dosage

REBOXETINE 4 MG TABLETS,EDRONAX 4 MG TABLETS - patient leaflet, side effects, dosage

Dostupné balení:


Sources: Original (products.mhra.gov.uk)

Patient leaflet - REBOXETINE 4 MG TABLETS,EDRONAX 4 MG TABLETS

(reboxetine methanesulphonate)

Patient Information Leaflet

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.

  • If you have any further questions, ask your doctor or pharmacist.

  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Your medicine is called Edronax 4mg Tablets/ Reboxetine 4mg Tablets but will be referred to as Edronax throughout this leaflet.

What is in this leaflet:

What Edronax is and what it is used for

What you need to know before you take Edronax

J3^ How to take Edronax

jj| Possible side effects

J5) How to store Edronax

Contents of the pack and other information

What Edronax is and what it is used for

The active substance in Edronax is reboxetine which is part of a group of medicines called antidepressants. Edronax is used in acute treatment of depressive illness / major depression as well as for maintaining the improvement of your symptoms when you have initially responded to treatment with reboxetine

What you need to know before you take Edronax

Do not take Edronax

  • If you are allergic to Reboxetine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Edronax

  • suffer from convulsions or epilepsy. Treatment with reboxetine should be stopped if seizures occur.

  • have any signs of urinary problems, enlarged prostate or a history of heart problems.

  • are taking medicines to lower your blood pressure.

  • have liver or kidney problems. Your doctor may need to adjust your dosage.

  • are taking any other medicine for depression such as MAO inhibitors, tricyclics, nefazodone, SSRIs (such as fluvoxamine) or lithium.

  • are taking other MAO inhibitors such as linezolid (an antibiotic) or methylene blue (see section “Other medicines and Edronax”).

  • ever had episodes of mania (overactive behaviour or thoughts).

  • have eye problems, such as certain kinds of glaucoma (increased pressure in the eye).

Thoughts of suicide and worsening of your depression:

If you are depressed you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.

You may be more likely to think like this:

  • – If you have previously had thoughts about killing or harming yourself. – If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed, and ask them to read this leaflet. You might ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behaviour.

Children and adolescents

Edronax should not usually be used in children and adolescents less than 18 years old. Patients under 18 have an increased risk of undesirable effects, such as suicide attempt, suicidal thoughts and hostility (mainly aggressiveness, oppositional behaviour and anger) when they are treated with this class of medicines. Nevertheless, it is possible that your doctor decides to prescribe Edronax to a patient under 18 if it is in the patient’s interest. If your doctor has prescribed Edronax to a patient less than 18 years old and you want to discuss this, please contact him/her. Furthermore, if any of the symptoms listed above appear or worsen when a patient under 18 is taking Edronax, you should inform your doctor.

Also, the long-term safety of Edronax in regard to growth, maturation and cognitive and behavioural development in this age group has not yet been demonstrated.

Other medicines and Edronax

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Edronax may affect or be affected by other medicines. These include:

  • Certain antifungals, e.g. ketoconazole

  • Certain antibiotics, e.g. erythromycin, rifampicin

  • Medicines called ergot derivatives used to treat migraine or Parkinson’s disease

  • Certain antidepressants called MAO inhibitors, tricyclics, nefazodone, SSRIs (such as fluvoxamine) or lithium

  • Other MAO inhibitors such as linezolid (an antibiotic) and methylene blue (used to treat high levels of methaemoglobin in the blood)

  • Any potassium-losing diuretics (medicines for eliminating water), e.g. thiazides

  • Medicines used to treat epilepsy e.g. phenobarbital, carbamazepine and phenytoin

  • * Herbal medicines containing St. John's Wort (Hypericum perforatum) Your doctor will tell you whether you can take Edronax with other medicines. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, herbal medicines, as well as vitamins and minerals.

Edronax with food and drink

Edronax can be taken with or without food.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

There are no adequate experiences from the use of Edronax in pregnant women. Do not take Edronax if you are pregnant, unless your doctor considers it absolutely necessary, following a careful clinical risk/benefit consideration. Tell your doctor immediately if you are pregnant or are planning to become pregnant.

Breast-feeding

Edronax passes into the breast milk in small amounts. There is a risk of a potential effect on the baby. Therefore, you should discuss the matter with your doctor and he/she will decide whether you should stop breast-feeding or stop the therapy with Edronax.

Driving and using machines

Caution is recommended when driving or using machines.

You should not drive or operate machinery until you know you are not affected (i.e. feel drowsy) by Edronax, and that it is safe to do so.

[31 How to take Edronax

(reboxetine methanesulphonate)

Patient Information Leaflet (continued)

If you forget to take Edronax

If you forget to take Edronax, take your next dose at the normal time. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Edronax

You should not stop your medicine without talking to your doctor, as your symptoms may come back.

There have been a few reports of withdrawal symptoms including headache, dizziness, nervousness and nausea (feeling sick), when patients stopped treatment with Edronax.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

[u Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. With Edronax most side effects are mild and usually go away after the first few weeks of treatment.

If any of the side effects below gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Very common side effects (more than one in 10 patients)

  • Difficulties to sleep (insomnia)

  • Dizziness

  • Dry mouth

  • Constipation

  • Nausea (feeling sick)

  • Sweating

Common side effects (less than one in 10 patients)

  • Headache

  • Lack or loss of appetite

  • Agitation, anxiety

  • Paraesthesia (pins and needles), inability to sit or stand still, altered taste sensation

  • Lack of visual focus

  • Increased heart rate, palpitation (heart pounding)

  • Widened blood vessels, fall in blood pressure when standing up, increased blood pressure

  • Vomiting

  • Rash

  • Sensation of incomplete emptying or slowed emptying of the bladder, urinary infection, painful urination, inability to completely empty the bladder

  • Erectile dysfunction (impotence), ejaculatory pain or ejaculatory delay

  • Chills

Uncommon side effects (between 1 and 10 out of 1000 patients)

  • Dilated pupils

  • Spinning sensation

Rare side effects (between 1 and 10 out of 10000 patients)

  • Glaucoma (a condition resulting in increased pressure in the eye)

After marketing Reboxetine, the following side effects have been reported:

  • Hyponatremia (very low levels of sodium in the blood)

  • Aggressive behaviour, hallucination

  • Suicidal ideation, Suicidal behaviour

Cases of suicidal ideation and suicidal behaviours have been reported during reboxetine therapy or early after treatment discontinuation

(see section 2 “Warnings and precautions”)

  • Cold extremities, Raynaud’s phe­nomenon (poor blood circulation to the extremities usually in the toes and fingers but could also affect nose and ears, the skin turns pale and becomes cold and numb)

  • Allergic skin inflammation

  • Testicular pain

  • Irritability

  • * Increased pressure in the eye

[ft How to store Edronax

Expiry date

Do not use this medicine after the expiry date shown on the carton label or blister strip.

If your doctor tells you to stop taking this medicine, return any unused tablets to your pharmacist (chemist) for safe disposal. Only keep this medicine, if your doctor tells you to.

If your tablets become discoloured or show any other signs of deterioration, consult your pharmacist (chemist) who will tell you what to do.

Storing your medicine

  • KEEP THIS MEDICINE OUT OF THE SIGHT AND REACH OF CHILDREN.

  • Do not store above 25°C.

  • * Do not take your tablets out of the blister strip until it is time to take your dose.

7) contents of the pack and other information

What this medicine contains:

Each tablet contains 4mg reboxetine (as methanesulphonate) as the active ingredient.

Your medicine also contains the following inactive ingredients: Cellulose microcrystalline, calcium hydrogen phosphate dihydrate, crospovidone, colloidal hydrated silica and magnesium stearate.

What this medicine looks like and contents of the pack

Edronax is a white, round, convex tablets one side has ‚7671‘ impressed on it and the other side has ‚P‘ a break line and ‚U‘ on the other side of the break line. Edronax are available in blister strips in packs of 60.

Manufacturer and Licence Holder

The tablets are manufactured by Pfizer Italia S.r.I., Localita Marino del Tronto – 63100 Ascoli Piceno, Italy and are procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE.

If you have any questions or are not sure about anything, ask your doctor or pharmacist. They will have additional information about this medicine and will be able to advise you.

POM PL 15184/0533 Edronax 4mg Tablets / Reboxetine 4mg Tablets

Edronax is a registered trademark ofPharmacia Italia S.p.A.

Revision date: 10/01/19

Blind or partially sighted?

Is this leaflet hard to see or read?

Phone Lexon (UK) Limited,

Tel: 01527 505414 to obtain the leaflet in a format suitable for you

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card Scheme website:

Sources: Original (products.mhra.gov.uk)